Home › Research › Biomarkers
Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later
Clémence Cavaillès, Mercedes R Carnethon, Kristen L Knutson, Stephen Justin Thomas, Kristine Yaffe. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026-04
Topic: Brain imaging, connectivity and assessment
Plain-language summary
After multivariable adjustment, longer sleep duration was associated with lower Aβ42/40, poor sleep quality with higher NfL, daytime sleepiness with both lower Aβ42/40 and higher NfL, and insomnia symptoms with higher SPARE-AD. No associations were observed with sleep and p-tau217. Poor sleep in early midlife was associated with unfavorable AD biomarker levels 20 years later, supporting the idea of sleep as a potential modifiable AD risk factor.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cavaillès, C., Carnethon, M. R., Knutson, K. L., Thomas, S. J., & Yaffe, K. (2026). Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71342
Vancouver
Cavaillès C, Carnethon MR, Knutson KL, Thomas SJ, Yaffe K. Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2026. doi:10.1002/alz.71342. PMID: 41981266.
BibTeX
@article{cavailles2026-41981266,
author = {Cavaillès, Clémence and Carnethon, Mercedes R and Knutson, Kristen L and Thomas, Stephen Justin and Yaffe, Kristine},
title = {{Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later}},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2026},
doi = {10.1002/alz.71342},
pmid = {41981266},
url = {https://doi.org/10.1002/alz.71342}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- After multivariable adjustment, longer sleep duration was associated with lower Aβ42/40, poor sleep quality with higher NfL, daytime sleepiness with both lower Aβ42/40 and higher NfL, and insomnia symptoms with higher SPARE-AD.
- No associations were observed with sleep and p-tau217.
- Poor sleep in early midlife was associated with unfavorable AD biomarker levels 20 years later, supporting the idea of sleep as a potential modifiable AD risk factor.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants1,325
- Evidence strengthLow
How this study scored 59/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 33 of the 56 points we could judge it on, which is 59 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,325 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41981266) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 33 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 33 of the 56 points we could judge it on is 59 out of 100. |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “apnea”
196 studies in the library carry the topic tag “apnea”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 196 tagged studies.